These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24819639)

  • 1. Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis.
    Peris K; Neri L; Fargnoli MC; Pellacani G
    G Ital Dermatol Venereol; 2014 Apr; 149(2):193-8. PubMed ID: 24819639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
    Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
    G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.
    Berman B; Cohen DE; Amini S
    Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
    Berman B; Cohen DE; Amini S
    Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of actinic keratosis: an update.
    Berman B; Amini S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
    Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian guidelines and therapeutic algorithm for actinic keratoses.
    Rossi R; Calzavara-Pinton PG; Giannetti A; Peserico A; Santucci M; Vena GA; Lotti T
    G Ital Dermatol Venereol; 2009 Dec; 144(6):713-23. PubMed ID: 19907409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
    Lee AD; Jorizzo JL
    Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment considerations in actinic keratosis.
    Goldenberg G
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of patient-centred care to overcome barriers in the management of actinic keratosis.
    Cerio R
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():17-20. PubMed ID: 28263022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical management of actinic keratosis and field cancerisation.
    Stockfleth E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician perceptions and experience of current treatment in actinic keratosis.
    Stockfleth E; Peris K; Guillen C; Cerio R; Basset-Seguin N; Foley P; Sanches J; Culshaw A; Erntoft S; Lebwohl M
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):298-306. PubMed ID: 25065394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.
    Berry K; Butt M; Kirby JS
    JAMA Dermatol; 2017 May; 153(5):421-426. PubMed ID: 28114674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapies for actinic keratosis.
    Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
    Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
    Noels EC; Hollestein LM; van Egmond S; Lugtenberg M; van Nistelrooij LPJ; Bindels PJE; van der Lei J; Stern RS; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Sep; 181(3):544-553. PubMed ID: 30636037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swiss clinical practice guidelines on field cancerization of the skin.
    Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M
    Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current issues in the management of actinic keratosis.
    Ceilley RI; Jorizzo JL
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S28-38. PubMed ID: 23228304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Schmitt AR; Bordeaux JS
    Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
    Basset-Seguin N
    Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.